ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2693 • 2018 ACR/ARHP Annual Meeting

    What Is the Effect of Cyclophosphamide Iv Pulse Therapy in Patients with Diffuse Cutaneous Systemic Sclerosis on Skin Involvement: An Observational Study

    Brigit Kersten, Nathan den Broeder, Frank van den Hoogen, Els van den Ende and Madelon Vonk, Rheumatology, Radboud University Medical Center, Nijmegen, Netherlands

    Background/Purpose: Patients with systemic sclerosis who have proximal skin involvement are classified as diffuse cutaneous systemic sclerosis (DcSSc). Patients with progressive skin involvement have worse prognosis.…
  • Abstract Number: 2694 • 2018 ACR/ARHP Annual Meeting

    Performance of Anti-Scl-70 Antibody Testing By Multiple-Bead, Enzyme-Linked Immunosorbent Assay, and Immunodiffusion in a University Setting

    Kate Homer1, Jeffery Warren2, Dmitry Karayev3, Puja P. Khanna4, Amber Young5, Vivek Nagaraja5, Allan L. Metzger6 and Dinesh Khanna5, 1Department of Internal Medicine, Rheumatology Division, Scleroderma Program, University of Michigan, Ann Arbor, MI, 2Department of Pathology, University of Michigan, Ann Arbor, MI, 3RDL Reference Laboratory, Santa Monica, CA, 4University of Michigan, Ann Arbor, MI, 5Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, 6RDL Reference Laboratory, Los Angeles, CA

    Background/Purpose: The gold standard for anti-Scl-70 antibody testing in systemic sclerosis (SSc) uses immunodiffusion (ID) techniques, but enzyme-linked immunosorbent assay (ELISA) and multi-bead technology are…
  • Abstract Number: 2695 • 2018 ACR/ARHP Annual Meeting

    Progressive Skin Fibrosis, Internal Organ Involvement and All-Cause Mortality in an Early Diffuse Cutaneous Systemic Sclerosis United States Multicenter Registry

    Kate Homer1, Benjamin Brennan2, Shervin Assassi3, Elana J. Bernstein4, Flavia V. Castelino5, Robyn T. Domsic6, Jessica K. Gordon7, Faye N. Hant8, Monique Hinchcliff9, Ami A. Shah10, Victoria Shanmugam11, Virginia D. Steen12, Veronica J. Berrocal13, Melanie Hemmrich14, Tracy M. Frech15 and Dinesh Khanna16, 1Department of Internal Medicine, Rheumatology Division, Scleroderma Program, University of Michigan, Ann Arbor, MI, 2School of Public Health, University of Michigan, Ann Arbor, MI, 3University of Texas McGovern Medical School, Houston, TX, 4Rheumatology, Columbia University, New York, NY, 5Rheumatology, Harvard Medical School, Boston, MA, 6Medicine - Rheumatology, University of Pittsburgh, Pittsburgh, PA, 7Rheumatology, Hospital for Special Surgery, New York, NY, 8Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, 9Rheumatology, Northwestern University, Chicago, IL, 10Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 11Rheumatology, The George Washington University, Washington, DC, 12Rheumatology, MedStar Georgetown University Hospital, Washington, DC, 13Div of Rheumatology, University of Michigan, Ann Arbor, MI, 14Bayer AG, Wuppertal, Germany, 15Division of Rheumatology, University of Utah, Salt Lake City, UT, 16Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI

    Background/Purpose: Early diffuse cutaneous systemic sclerosis (dcSSc) carries a high morbidity and mortality, predominantly due to internal organ involvement. The purpose of this study was…
  • Abstract Number: 2696 • 2018 ACR/ARHP Annual Meeting

    Increased Mortality in Black and Asian Patients with Systemic Sclerosis in Northern California

    Melody Chung1, Makdine Dontsi2, Debbie Postlethwaite2, Sumana Kesh3, Lisa Zaba4 and Lorinda Chung5,6, 1Internal Medicine Residency, Kaiser Permanente Santa Clara, Santa Clara, CA, 2Division of Research, Kaiser Permanente Northern California, Oakland, CA, 3Department of Internal Medicine, Kaiser Permanente Santa Clara, Santa Clara, CA, 4Department of Dermatology, Kaiser Permanente Santa Clara, Santa Clara, CA, 5Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 6VA Palo Alto Health Care System, Palo Alto, CA

    Background/Purpose: Studies indicate that black patients with systemic sclerosis (SSc) demonstrate a distinct phenotypic profile, with more severe disease, heightened mortality, and poorer prognosis compared…
  • Abstract Number: 2697 • 2018 ACR/ARHP Annual Meeting

    Elevated Serum Interleukin-34 Levels Are Correlated with Interstitial Lung Disease in Systemic Sclerosis

    Hiraku Suga1, Ai Kuzumi1, Yoshihide Asano1, Ayumi Yoshizaki1 and Shinichi Sato2, 1Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2The University of Tokyo, Department of Dermatology, Tokyo, Japan

    Background/Purpose: Interleukin (IL)-34 is a hematopoietic cytokine, which promotes survival, proliferation, and differentiation of monocytes and macrophages. We investigated serum IL-34 levels in patients with…
  • Abstract Number: 2698 • 2018 ACR/ARHP Annual Meeting

    Renal Involvement in Mixed Connective Tissue Disease: A Single Center Experience

    Eduardo Martín Nares1, Silvia Eunice Ramírez Andrade2, Luis Eduardo Morales Buenrostro2, Norma Ofelia Uribe Uribe3, Laura R Cárdenas M3, Montserrat Reyes Macedo3 and Tatiana S. Rodriguez-Reyna1, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Department of Nephrology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 3Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    Background/Purpose: Kidney injury in mixed connective tissue disease (MCTD) is an uncommon manifestation. Prevalence has been reported to be <4% in some cohorts. The frequency…
  • Abstract Number: 2699 • 2018 ACR/ARHP Annual Meeting

    Using ICD-10 Codes to Identify Patients with Systemic Sclerosis in the Electronic Health Record

    Lia Jamian1, Leslie Crofford2 and April Barnado2, 1Medicine, Vanderbilt University Medical Center, Nashville, TN, 2Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Pragmatic research in rare diseases is difficult, largely limited by small sample size and single center cohort studies.  The electronic health record (EHR) can…
  • Abstract Number: 2700 • 2018 ACR/ARHP Annual Meeting

    Rescuing Standard Analyses of Immunosuppresive Rescue Therapy in Randomized Controlled Trials: Alternative Approaches in a Scleroderma Clinical Trial

    Cathie Spino1, Robert A. Parker2 and Dinesh Khanna3, 1Biostatistics, University of Michigan, Ann Arbor, MI, 2Medicine-Massachusetts General Hospital, Harvard Medical School, Boston, MA, 3Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI

    Background/Purpose: Placebo-controlled clinical trials are the gold standard to provide the highest-quality evidence of treatment efficacy; however, in early SSc, requiring participants to take long-term…
  • Abstract Number: 2701 • 2018 ACR/ARHP Annual Meeting

    Botulinum Toxin in the Management of Raynaud’s Phenomenon

    Daniel Ennis1,2, Zareen Ahmad3, Keshini Devakandan1, Melanie A Anderson4 and Sindhu Johnson1, 1Toronto Scleroderma Program, Mount Sinai Hospital, Toronto Western Hospital, Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, ON, Canada, 2Rheumatology, University of British Columbia, Vancouver, BC, Canada, 3Toronto Scleroderma Program, Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 4University Health Network Library Services, Toronto General Hospital, Toronto, ON, Canada

    Background/Purpose: The objectives of this study were to evaluate the effectiveness and safety of botulinum toxin injection in Raynaud’s phenomenon. Methods: Medline and Embase databases…
  • Abstract Number: 2702 • 2018 ACR/ARHP Annual Meeting

    Incidence, Prevalence, Mortality and Comparison of the Acr/EULAR 2013 Classification Criteria with 1980 Criteria in Physician Diagnosed Systemic Sclerosis: Results from a Population Based Cohort (1980-2016)

    Avneek Singh Sandhu1, Cynthia S. Crowson2, Philippe R. Bauer3, Eric L. Matteson4 and Ashima Makol1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, 3Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, 4Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN

    Background/Purpose: Systemic Sclerosis (SSc) is a complex and heterogenous chronic inflammatory disease characterized by widespread fibrosis of the skin and visceral organs, microvascular injury and…
  • Abstract Number: 2703 • 2018 ACR/ARHP Annual Meeting

    Delay in Initiation of Therapy Predicts Worse Outcomes in Scleroderma Renal Crisis

    Aditi Patel1, Kinjal Banerjee2 and Soumya Chatterjee3, 1Internal Medicine, Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic, Cleveland, OH, 3Rheumatic and Immunologic Disease, Cleveland Clinic, Cleveland, OH

    Background/Purpose: Scleroderma renal crisis (SRC) is a rare complication of patients with systemic sclerosis (SSc). ACE inhibitors (ACEI) favorably alter the natural history of this…
  • Abstract Number: 2704 • 2018 ACR/ARHP Annual Meeting

    Pregnancy in Systemic Sclerosis (SSc): A Systematic Review and Meta-Analysis

    Jelena Blagojevic1, Khitam Abdullah AlOdhaibi2, Aly M Aly3, Marco Matucci-Cerinic4 and Daniel E. Furst5,6,7, 1Department of Experimental and Clinical Medicine, University of Florence, Division of Rheumatology AOUC, Florence, Italy, 2Department of Family Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia, 3Alexandria University Faculty of Medicine, Alexandria, Egypt, 4Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy, 5University of California, Los Angeles (UCLA), Los Angeles, CA, 6University of Florence, Florence, Italy, 7University of Washington, Seattle, WA

    Background/Purpose: In a systematic literature review and meta-analysis, to determine maternal and fetal outcomes in pregnant SSc women and to analyse the effect of pregnancy…
  • Abstract Number: 2705 • 2018 ACR/ARHP Annual Meeting

    Optimized Protocol for Extracorporeal Shock Wave Therapy on Digital Ulcers in Systemic Sclerosis

    Tomonori Ishii1, Yasushi Kawaguchi2, Osamu Ishikawa3, Hiromitsu Takemori4, Naruhiko Takasawa5, Hitoshi Kobayashi6, Yuichi Takahashi7, Hidekata Yasuoka8, Takao Kodera9, Osamu Takai10, Izaya Nakaya11, Tomomasa Izumiyama12, Hiroshi Fujii13, Yukiko Kamogawa13, Yuko Shirota13, Tsuyoshi Shirai13, Yoko Fujita14, shinichiro saito15, Hiroaki Shimokawa16 and Hideo Harigae13, 1Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Japan, 2Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 3Department of Dermatology, Gunma University Graduate School of Medicine, gunma, Japan, 4Aomori Prefectural Central Hospital, Aomori, Japan, 5Department of Internal Medicine, Tohoku Medical and Pharmaceutical University Wakabayashi Hospital, Sendai, Japan, 6Iwate Medical University Hospital, Morioka, Japan, 7Yu Family Clinic, Sendai, Japan, 8Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, tokyo, Japan, 9Division of Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, 10Osaki Citizen Hospital, Sendai, Japan, 11Department of Nephrology and Rheumatology, Iwate Prefectural Central Hospital, Morioka, Japan, 12Higashisendai Rheumatic Disease Clinic, Sendai, Japan, 13Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan, 14Department of Hematolgy and Rheumatolgy, Tohoku University Graduate School of Medicine, Sendai, Japan, 15IMS Meirikai Sendai General Hospital, Sendai, Japan, 16Department of Cardiovascular medicine, Tohoku University Graduate School of Medicine, Sendai, Japan

    Background/Purpose: Extracorporeal shock wave therapy (ESWT) at low energy has been shown to be effective for digital ulcers in systemic sclerosis (SSc) in our study…
  • Abstract Number: 2706 • 2018 ACR/ARHP Annual Meeting

    Discriminant Validity and Reliability of World Scleroderma Foundation (WSF) Definition of Skin Ulcers in Systemic Sclerosis

    Yossra A Suliman1, Cosimo Bruni2, Sindhu Johnson3, Suzanne Kafaja4, Emanuela Praino5, Dinesh Khanna6, Yannick Allanore7, Murray Baron8, Jonathan Grotts9, Thomas Krieg10, Ariane L. Herrick11, Christopher P. Denton12, Marco Matucci-Cerinic13 and Daniel E. Furst14, 1Rheumatology and Rehabilitation dept., Rheumatology and Rehabilitation dept. Assiut university hospital, Assiut Egypt, Assiut, Egypt, 2Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Firenze, Italy, 3Toronto Scleroderma Program, Toronto Western Hospital, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 4David Geffen School of Medicine, UCLA, Los Angeles, CA, 5DIM, Rheumatology Unit - D.E.T.O. - University of Bari (ITALY), Bari, Italy, 6Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, 7Service de Rhumatologie A, Hôpital Cochin, Paris, France, 8Rheumatology, Jewish General Hospital, Montreal, QC, Canada, 9Biostatistics, University of California Los Angeles, Los Angeles, CA, 10Universität zu Köln, Köln, Germany, 11Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, United Kingdom, 12UCL Division of Medicine, Royal Free Campus, London, United Kingdom, 13Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy, 14Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA

    Background/Purpose: To date, there is lack of a uniform definition of systemic sclerosis related skin ulcer (SSc-skin ulcer) for use in clinical trials. Our group…
  • Abstract Number: 2707 • 2018 ACR/ARHP Annual Meeting

    Scleroderma Renal Crisis: The Association of High-Dose Steroids and Poor Outcome

    Nilasha Ghosh1, Xuan Cai2 and Cybele Ghossein3, 1Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Nephrology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Scleroderma renal crisis (SRC) is the most acute and life-threatening complication of scleroderma characterized by sudden increase in blood pressure and worsening kidney function.…
  • « Previous Page
  • 1
  • …
  • 1182
  • 1183
  • 1184
  • 1185
  • 1186
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology